| " What do You Want Here?"-Decision-Making in Primary Health Care A Klement, S Frantz Deutsche Medizinische Wochenschrift (1946) 144 (10), 637-638, 2019 | | 2019 |
| “Core Reviewers” who have reviewed for Cardiovascular Research five to seven times over the twelve-month period ending October 31, 2014 P Aaronson, E Aavik, M Aikawa, T Akiyama, B Annex, M Aslam, M Babu, ... | | |
| „Erwachsene mit angeborenen Herzfehlern “: Aktuelle Herausforderung in der medizinischen Versorgung Teil II: Infektiöse Endokarditis, pulmonale Hypertonie, Aortopathien … H Kaemmerer, S Baldus, H Baumgartner, F Berger, F de Haan, S Frantz, ... Die Kardiologie 17 (5), 282-299, 2023 | 2 | 2023 |
| „Was wollen Sie denn hier?“–Entscheidungen in der Primärversorgung A Klement, S Frantz DMW-Deutsche Medizinische Wochenschrift 144 (10), 637-638, 2019 | | 2019 |
| 161 Impact of right ventricular dysfunction on outcome in heart failure patients with mid-range ejection fraction with and without chronic respiratory diseases D Liu, K Hu, C Scheffold, F Liebner, M Kirch, B Lengenfelder, G Ertl, ... European Heart Journal-Cardiovascular Imaging 21 (Supplement_1), jez319. 039, 2020 | | 2020 |
| 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment … TA McDonagh, M Metra, M Adamo, RS Gardner, A Baumbach, M Böhm, ... European Heart Journal 44 (37), 3627-3639, 2023 | 600 | 2023 |
| 2355 Treatment of cardiac manifestations in Fabry disease with the oral drug Migalastat: First 12 months results from a cohort of amenable all-comers J Muentze, D Gensler, T Salinger, D Oder, C Wanner, S Frantz, ... European Heart Journal 39 (suppl_1), ehy565. 2355, 2018 | 2 | 2018 |
| 2455 Predictive value of diastolic dysfunction severity on long-term survival in heart failure patients with mid-range or reduced left ventricular ejection fraction D Liu, K Hu, K Lau, C Hammel, T Salinger, S Herrmann, G Ertl, S Frantz, ... European Heart Journal 39 (suppl_1), ehy565. 2455, 2018 | | 2018 |
| 372 Transforming growth factor inhibition increases mortality and left ventricular dilatation after myocardial infarction S Frantz, K Hu, A Adamek, J Wolf, AQ Sallam, G Ertl, J Bauersachs European Journal of Heart Failure Supplements 6, 86-86, 2007 | | 2007 |
| 4092 Magnetic resonance imaging of Fabry disease cardiomyopathy in patients receiving oral chaperone therapy J Muentze, D Gensler, T Cairns, O Maniuc, D Oder, C Wanner, S Frantz, ... European Heart Journal 40 (Supplement_1), ehz745. 0104, 2019 | | 2019 |
| 411 Recompensation induces distinct changes in myocardial work in patients with acutely decompensated heart failure and reduced vs preserved left ventricular ejection fraction C Morbach, F Sahiti, C Henneges, M Breunig, M Kaspar, G Ertl, S Frantz, ... European Heart Journal-Cardiovascular Imaging 21 (Supplement_1), jez319. 227, 2020 | | 2020 |
| 5-HTT deficiency affects early healing processes after myocardial infarction S Popp, U Hofmann, L Hommers, K Schuh, S Frantz, KP Lesch, A Frey ZEITSCHRIFT FUR PSYCHOSOMATISCHE MEDIZIN UND PSYCHOTHERAPIE 67 (2), 171-172, 2021 | | 2021 |
| 5-HTT deficiency in Male mice affects healing and behavior after myocardial infarction S Popp, A Schmitt-Böhrer, S Langer, U Hofmann, L Hommers, K Schuh, ... Journal of Clinical Medicine 10 (14), 3104, 2021 | 6 | 2021 |
| 5-Lipoxygenase facilitates healing after myocardial infarction N Blömer, C Pachel, U Hofmann, P Nordbeck, W Bauer, D Mathes, A Frey, ... Basic research in cardiology 108, 1-10, 2013 | 46 | 2013 |
| 5-Lipoxygenase Facilitates Healing after Myocardial Infarction C Pachel, N Bloemer, U Hofmann, P Nordbeck, W Bauer, A Podolskaya, ... Circulation 124 (suppl_21), A12413-A12413, 2011 | | 2011 |
| 5-year outcome comparison among aortic stenosis patients underwent transcatheter aortic valve implantation with or without permanent pacemaker D Liu, K Hu, V Sokalski, K Lau, B Lengenfelder, G Ertl, S Frantz, ... European Heart Journal 44 (Supplement_2), ehad655. 1625, 2023 | | 2023 |
| 584 Prevention of cardiac hypertrophy and failure in vivo by a novel microRNA antagonist T Thum, C Gross, J Fiedler, P Galuppo, S Frantz, K Hu, G Ertl, ... European Journal of Heart Failure Supplements 7, 146-146, 2008 | 1 | 2008 |
| 62 Verbesserte kardiopulmonale Leistungsfähigkeit, Herzstruktur und Lebensqualität nach bariatrischer Operation–Ergebnisse der randomisierten Würzburger Adipositas Studie (WAS) AC Koschker, B Warrings, C Morbach, F Seyfried, P Jung, U Dischinger, ... Adipositas-Ursachen, Folgeerkrankungen, Therapie 15 (03), 2021 | | 2021 |
| 673 Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure G Gueder, J Bauersachs, S Frantz, D Weismann, B Allolio, G Ertl, ... European Journal of Heart Failure Supplements 6, 146-146, 2007 | 2 | 2007 |
| 674 Prognostic value of androgens in male patients with chronic heart failure S Stoerk, G Gueder, S Frantz, J Bauersachs, D Weismann, B Allolio, G Ertl, ... European Journal of Heart Failure Supplements 6, 146-147, 2007 | | 2007 |
